Given our findings that genetic variation in rs2241766 of ADIPOQ gene modified the risk of poor glycemic control, we wanted to test if genetic variations in that locus were associated with differences in serum adiponectin levels in T2DM patients of our population. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.